Armata Pharmaceuticals (ARMP) Cash from Operations (2013 - 2026)

Armata Pharmaceuticals has disclosed Cash from Operations across 14 years of filings, most recently posting 5782000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 5782000.0, up 23.72% year-over-year; the trailing twelve-month figure through Mar 2026 was 23965000.0 (up 30.63% YoY), and the FY2025 annual result was 25763000.0, up 31.39% from the prior year.
• Cash from Operations came in at 5782000.0 for Q1 2026 at Armata Pharmaceuticals, up from 6674000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 3515000.0 in Q1 2022 to a low of 17570000.0 in Q1 2023.
• The 5-year median for Cash from Operations is 8148000.0 (2022), against an average of 8764705.88.
• Across the five-year window, Cash from Operations slumped 399.86% in 2023 and jumped 51.51% in 2025, its largest moves.
• Armata Pharmaceuticals' Cash from Operations stood at 10485000.0 in 2022, then increased by 22.69% to 8106000.0 in 2023, then advanced by 2.21% to 7927000.0 in 2024, then advanced by 15.81% to 6674000.0 in 2025, then increased by 13.37% to 5782000.0 in 2026.
• The last three Cash from Operations figures came in at 5782000.0 (Q1 2026), 6674000.0 (Q4 2025), and 4298000.0 (Q3 2025), per Business Quant data.